Market Research Industry Reports

Sunglasses in Australia

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Despite the decline in average unit price, sunglasses is set to register value growth at constant 2018 prices over the forecast period, with growth supported by an increase in volume sales. This performance is expected to be driven primarily by sunglasses transitioning from being purely functional eyewear to a fashion accessory and more frequently worn as an expression of personal style. As a result, the category is becoming less seasonal with more consumers purchasing multiple pairs to complet...

The Internationals Sunglasses in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2013-2017), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market be they new product developments, distribution or pricing issues. Forecasts to 2022 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Sunglasses market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


SUNGLASSES IN AUSTRALIA



LIST OF CONTENTS AND TABLES

Headlines
Prospects
Sunglasses Projected To Post Positive Value Growth Over the Forecast Period
Online Sales of Sunglasses Set To Grow Over the Forecast Period
Small Niche Brands Focus on Social Media Marketing To Drive Brand Awareness
Competitive Landscape
Luxottica Australia Retains Its Outright Category Lead in 2017
Sunshades Eyewear Registers the Fastest Value Growth in 2017
Rapidly Changing Fashion Trends Support Growth Momentum
Category Data
Table 1 Sales of Sunglasses: Volume 2013-2018
Table 2 Sales of Sunglasses: Value 2013-2018
Table 3 Sales of Sunglasses: % Volume Growth 2013-2018
Table 4 Sales of Sunglasses: % Value Growth 2013-2018
Table 5 NBO Company Shares of Sunglasses: % Value 2013-2017
Table 6 LBN Brand Shares of Sunglasses: % Value 2014-2017
Table 7 Distribution of Sunglasses by Format: % Value 2013-2018
Table 8 Forecast Sales of Sunglasses: Volume 2018-2023
Table 9 Forecast Sales of Sunglasses: Value 2018-2023
Table 10 Forecast Sales of Sunglasses: % Volume Growth 2018-2023
Table 11 Forecast Sales of Sunglasses: % Value Growth 2018-2023
Executive Summary
Australias Eyewear Industry Continues To Post Positive Value Growth in 2018
Fashion Trends Have A Significant Influence on Sunglasses and Spectacle Frames
International Brands Continue To Characterise Australias Eyewear Market
Bricks-and-mortar Stores Remain Relevant Despite Strong Growth of Internet Retailing
Australias Eyewear Industry Projected To Post Positive Growth in the Forecast Period
Market Data
Table 12 Sales of Eyewear by Category: Volume 2013-2018
Table 13 Sales of Eyewear by Category: Value 2013-2018
Table 14 Sales of Eyewear by Category: % Volume Growth 2013-2018
Table 15 Sales of Eyewear by Category: % Value Growth 2013-2018
Table 16 NBO Company Shares of Eyewear: % Value 2013-2017
Table 17 LBN Brand Shares of Eyewear: % Value 2014-2017
Table 18 Distribution of Eyewear by Format: % Value 2013-2018
Table 19 Forecast Sales of Eyewear by Category: Volume 2018-2023
Table 20 Forecast Sales of Eyewear by Category: Value 2018-2023
Table 21 Forecast Sales of Eyewear by Category: % Volume Growth 2018-2023
Table 22 Forecast Sales of Eyewear by Category: % Value Growth 2018-2023
Definitions
Sources
Summary 1 Research Sources













Tricida Inc (TCDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tricida Inc (Tricida), formerly Trilypsa Inc is a clinical-stage pharmaceutical and drug discovery company. The company discovers and develops novel non-absorbed therapies for the treatment of renal, metabolic and cardiovascular

USD 250View Report

Elsalys Biotech SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Elsalys Biotech SA (Elsalys Biotech) is a pharmaceutical company that develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases. The companys pipeline

USD 250View Report

Tricida Inc (TCDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tricida Inc (Tricida), formerly Trilypsa Inc is a clinical-stage pharmaceutical and drug discovery company. The company discovers and develops novel non-absorbed therapies for the treatment of renal, metabolic and cardiovascular

USD 250View Report

Elsalys Biotech SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Elsalys Biotech SA (Elsalys Biotech) is a pharmaceutical company that develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases. The companys pipeline

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 990
$ 990

Reports Details

Published Date : Jul 2018
No. of Pages :13
Country :Australia
Category :Personal Care
Publisher :Euromonitor
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube